Hollencrest Capital Management Merck & Co., Inc. Transaction History

Hollencrest Capital Management

$2.41 Billion
Q4 2024

A detailed history of Hollencrest Capital Management transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hollencrest Capital Management holds 5,819 shares of MRK stock, worth $520,800. This represents 0.02% of its overall portfolio holdings.

Number of Shares

5,819

Previous 6,131 5.09%

Holding current value

$520,800

Previous $696,000 16.95%

% of portfolio

0.02%

Previous 0.03%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$96.31 - $114.76 $30,048 - $35,805	-312 Reduced 5.09%	5,819 $578,000
Q3 2024 Oct 31, 2024	BUY	$111.15 - $128.97 $43,681 - $50,685	393 Added 6.85%	6,131 $696,000
Q2 2024 Aug 12, 2024	BUY	$123.8 - $132.96 $123 - $132	1 Added 0.02%	5,738 $710,000
Q4 2023 Feb 14, 2024	BUY	$100.18 - $109.02 $31,356 - $34,123	313 Added 5.77%	5,737 $625,000
Q3 2023 Nov 13, 2023	BUY	$102.95 - $114.33 $102 - $114	1 Added 0.02%	5,424 $558,000
Q1 2023 May 16, 2023	BUY	$102.94 - $114.86 $102 - $114	1 Added 0.02%	5,423 $576,000
Q4 2022 Feb 06, 2023	BUY	$87.44 - $112.11 $474,099 - $607,860	5,422 New	5,422 $601,000
Q2 2022 Jul 21, 2022	BUY	$83.49 - $94.64 $83 - $94	1 Added 0.02%	5,875 $536,000
Q1 2022 Apr 18, 2022	BUY	$73.51 - $82.4 $73 - $82	1 Added 0.02%	5,874 $482,000
Q4 2021 Jan 07, 2022	SELL	$72.28 - $90.54 $7,155 - $8,963	-99 Reduced 1.66%	5,873 $450,000
Q2 2021 Jul 21, 2021	BUY	$70.31 - $77.77 $70 - $77	1 Added 0.02%	5,972 $465,000
Q1 2021 Apr 29, 2021	SELL	$68.86 - $81.11 $48,821 - $57,506	-709 Reduced 10.61%	5,971 $461,000
Q4 2020 Jan 26, 2021	SELL	$71.77 - $79.65 $28,133 - $31,222	-392 Reduced 5.54%	6,680 $547,000
Q3 2020 Oct 13, 2020	BUY	$73.18 - $82.95 $658 - $746	9 Added 0.13%	7,072 $586,000
Q2 2020 Jul 16, 2020	SELL	$70.42 - $80.13 $6,549 - $7,452	-93 Reduced 1.3%	7,063 $546,000
Q1 2020 May 01, 2020	SELL	$63.36 - $87.82 $237,156 - $328,710	-3,743 Reduced 34.34%	7,156 $550,000
Q4 2019 Jan 23, 2020	BUY	$77.58 - $87.54 $37,238 - $42,019	480 Added 4.61%	10,899 $991,000
Q3 2019 Oct 23, 2019	BUY	$76.08 - $82.93 $1,749 - $1,907	23 Added 0.22%	10,419 $877,000
Q2 2019 Jul 18, 2019	BUY	$69.84 - $81.59 $2,584 - $3,018	37 Added 0.36%	10,396 $872,000
Q4 2018 May 09, 2019	SELL	$65.24 - $75.71 $782 - $908	-12 Reduced 0.12%	10,359 $755,000
Q4 2018 Jan 03, 2019	BUY	$65.24 - $75.71 $782 - $908	12 Added 0.12%	10,371 $793,000
Q3 2018 May 09, 2019	SELL	$57.69 - $67.84 $44,075 - $51,829	-764 Reduced 6.87%	10,359 $862,000
Q3 2018 Oct 04, 2018	SELL	$57.69 - $67.84 $19,383 - $22,794	-336 Reduced 2.93%	11,123 $789,000
Q2 2018 Jul 10, 2018	SELL	$50.83 - $59.72 $3,558 - $4,180	-70 Reduced 0.61%	11,459 $0
Q1 2018 Apr 24, 2018	SELL	$50.96 - $59.23 $15,695 - $18,242	-308 Reduced 2.6%	11,529 $628,000
Q4 2017 Jan 19, 2018	SELL	$51.62 - $61.64 $209,061 - $249,642	-4,050 Reduced 25.49%	11,837 $0
Q3 2017 Oct 10, 2017	BUY	$58.67 - $63.13 $932,090 - $1 Million	15,887	15,887 $1.02 Million

Others Institutions Holding MRK

# of Institutions

3,952

Shares Held

1.94B

Call Options Held

16M

Put Options Held

15M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hollencrest Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Hollencrest Capital Management with notifications on news.

Account

Hollencrest Capital Management Merck & Co., Inc. Transaction History